We serve Chemical Name:1-benzyl-2-(trifluoromethyl)-4,5-dihydroimidazole CAS:1069085-40-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-benzyl-2-(trifluoromethyl)-4,5-dihydroimidazole
CAS.NO:1069085-40-0
Synonyms:1-benzyl-2-trifluoromethylimidazoline
Molecular Formula:C11H11F3N2
Molecular Weight:228.21400
HS Code:2933290090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:15.60000
Exact Mass:228.08700
LogP:1.83650
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-benzyl-2-trifluoromethylimidazoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzyl-2-trifluoromethylimidazoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl-2-trifluoromethylimidazoline Use and application,1-benzyl-2-trifluoromethylimidazoline technical grade,usp/ep/jp grade.
Related News: In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant. 1-benzyl-2-(trifluoromethyl)-4,5-dihydroimidazole manufacturer APIs are generally manufactured through a variety of processes that include. 1-benzyl-2-(trifluoromethyl)-4,5-dihydroimidazole supplier It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand. 1-benzyl-2-(trifluoromethyl)-4,5-dihydroimidazole vendor The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). 1-benzyl-2-(trifluoromethyl)-4,5-dihydroimidazole factory In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant.
